Research Article
Fetal and Maternal Outcomes of Planned Pregnancy in Patients with Systemic Lupus Erythematosus: A Retrospective Multicenter Study
Table 3
Association of different characteristics during pregnancy with APOs: results of multivariate analysis.
| Characteristics | value | OR | OR 95% CI |
| Fetal APOs | | | | Composite APOs | | | | Disease flares during pregnancy | <0.001 | 8.1 | 3.8–17.2 | Anticardiolipin antibody positivity | <0.001 | 7.4 | 2.5–21.8 | Fetal loss | | | | Disease flares during pregnancy | 0.002 | 28.4 | 3.4–239.0 | Anticardiolipin antibody positivity | 0.004 | 7.8 | 1.9–31.4 | Preterm birth | | | | Disease flares during pregnancy | 0.002 | 3.5 | 1.6–7.7 | PIH | <0.001 | 6.0 | 2.3–15.8 | IUGR | | | | PIH | <0.001 | 6.7 | 2.9–15.8 | Fetal distress | | | | PIH | <0.001 | 6.1 | 2.5–15.2 | Maternal APOs | | | | PIH | | | | Disease flares during pregnancy | <0.001 | 12.2 | 4.4–33.3 | Thrombocytopenia | 0.04 | 4.0 | 1.1–14.8 | aCL antibody positivity | <0.001 | 7.5 | 2.5–22.4 |
|
|